StonvexLoading…
StonvexStonvexStonvexCore line items from NG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-11-30 | Q2 2025 2025-05-31 | Q1 2025 2025-02-28 | Annual 2024 2024-11-30 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-47.29M | $-19.38M | $-7.10M | $-37.86M |
Net Income | $-94.66M | $-54.27M | $-9.12M | $-45.62M |
EPS (Diluted) | $-0.25 | $-0.19 | $-0.03 | $-0.14 |
Total Assets | $335.91M | $329.30M | $102.03M | $109.75M |
Total Liabilities | $172.12M | $164.02M | $158.15M | $157.17M |
Cash & Equivalents | $110.14M | $293.74M | $33.97M | $42.22M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 406.93M | 342.51M | 334.64M | 334.57M |